Healthcare provider profile · identity verified

Christopher Olsen, DO

Family Practice · HARDY, VA · NPI 1396308805

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	861	263
Amlodipine Besylate	Amlodipine Besylate	558	180
Lisinopril	Lisinopril	443	131
Levothyroxine Sodium	Levothyroxine Sodium	375	106
Losartan Potassium	Losartan Potassium	339	103
Rosuvastatin Calcium	Rosuvastatin Calcium	335	111
Omeprazole	Omeprazole	292	98
Hydrochlorothiazide	Hydrochlorothiazide	282	91
Metformin Hcl	Metformin Hcl	235	73
Pantoprazole Sodium	Pantoprazole Sodium	232	92
Gabapentin	Gabapentin	231	72
Tamsulosin Hcl	Tamsulosin Hcl	219	70
Trazodone Hcl	Trazodone Hcl	211	67
Simvastatin	Simvastatin	201	63
Ozempic	Semaglutide	187	31
Furosemide	Furosemide	185	63
Sertraline Hcl	Sertraline Hcl	185	69
Metoprolol Succinate	Metoprolol Succinate	164	52
Metoprolol Tartrate	Metoprolol Tartrate	160	51
Eliquis	Apixaban	154	39
Allopurinol	Allopurinol	150	45
Montelukast Sodium	Montelukast Sodium	150	45
Fluticasone Propionate	Fluticasone Propionate	148	60
Metformin Hcl Er	Metformin Hcl	144	41
Albuterol Sulfate Hfa	Albuterol Sulfate	128	53
Pravastatin Sodium	Pravastatin Sodium	124	37
Escitalopram Oxalate	Escitalopram Oxalate	117	37
Duloxetine Hcl	Duloxetine Hcl	109	34
Atenolol	Atenolol	106	35
Famotidine	Famotidine	106	37
Meloxicam	Meloxicam	100	34
Bupropion Xl	Bupropion Hcl	94	31
Carvedilol	Carvedilol	93	32
Jardiance	Empagliflozin	93	30
Glipizide	Glipizide	92	31
Ezetimibe	Ezetimibe	91	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	85	27
Olmesartan Medoxomil	Olmesartan Medoxomil	83	25
Alprazolam	Alprazolam	80	20
Clopidogrel	Clopidogrel Bisulfate	73	24
Zolpidem Tartrate	Zolpidem Tartrate	73	16
Pregabalin	Pregabalin	69	17
Prednisone	Prednisone	68	40
Synthroid	Levothyroxine Sodium	68	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	20
Warfarin Sodium	Warfarin Sodium	66	18
Diclofenac Sodium	Diclofenac Sodium	65	26
Triamcinolone Acetonide	Triamcinolone Acetonide	65	28
Potassium Chloride	Potassium Chloride	64	18
Glipizide Er	Glipizide	62	25
Venlafaxine Hcl Er	Venlafaxine Hcl	62	16
Tramadol Hcl	Tramadol Hcl	61	11
Citalopram Hbr	Citalopram Hydrobromide	60	15
Fluoxetine Hcl	Fluoxetine Hcl	58	21
Alendronate Sodium	Alendronate Sodium	56	18
Methocarbamol	Methocarbamol	56	16
Spironolactone	Spironolactone	56	17
Trulicity	Dulaglutide	55	suppressed
Celecoxib	Celecoxib	54	18
Lorazepam	Lorazepam	54	13
Meclizine Hcl	Meclizine Hcl	53	20
Tizanidine Hcl	Tizanidine Hcl	49	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	suppressed
Buspirone Hcl	Buspirone Hcl	46	16
Lovastatin	Lovastatin	46	13
Finasteride	Finasteride	43	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	14
Pioglitazone Hcl	Pioglitazone Hcl	42	14
Doxycycline Hyclate	Doxycycline Hyclate	41	35
Oxycodone Hcl	Oxycodone Hcl	41	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	36
Irbesartan	Irbesartan	38	11
Valacyclovir	Valacyclovir Hcl	38	16
Mounjaro	Tirzepatide	37	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	11
Clonazepam	Clonazepam	35	suppressed
Nystatin	Nystatin	34	13
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	14
Benazepril Hcl	Benazepril Hcl	32	suppressed
Cephalexin	Cephalexin	32	30
Chlorthalidone	Chlorthalidone	30	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	30	suppressed
Amoxicillin	Amoxicillin	29	18
Azithromycin	Azithromycin	29	27
Hydralazine Hcl	Hydralazine Hcl	29	14
Nitroglycerin	Nitroglycerin	28	11
Xarelto	Rivaroxaban	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Mirtazapine	Mirtazapine	27	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Valsartan	Valsartan	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Acyclovir	Acyclovir	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Ketoconazole	Ketoconazole	20	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	18
Diazepam	Diazepam	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Baclofen	Baclofen	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fluconazole	Fluconazole	16	11
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Torsemide	Torsemide	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Colchicine	Colchicine	13	12
Divalproex Sodium	Divalproex Sodium	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Topiramate	Topiramate	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Estradiol	Estradiol	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error